Search - tctmd.com

Displaying 681 - 700 of 1006

Sort: Relevancy | Date

Presentation TCT 2015

OPEN CTO - Procedural and 30-Day Results of Hybrid Strategy for CTO Recanalization

Presenter: R. Michael Wyman, James Sapontis

October 12, 2015

Presentation TCT 2015

Poor Femoral Access and TAVR (Alternative Access): Thoughtful Commentary on the Case

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Michael J. Reardon

October 12, 2015

Presentation TCT 2015

Case 4: Where Are the Guidewires? Two-Stent Treatment Guided by OCT

Presenter: Evald H. Christiansen, Andrejs Erglis, Michael Maeng

October 12, 2015

Presentation TCT 2015

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold - Six-Month Clinical, Angiographic and Imaging Outcomes

Presenter: Ioanna Kosmidou, Michael Haude

October 12, 2015

Presentation TCT 2015

Transcatheter Valve Replacement for Native Mitral Stenosis: International Registry Results

Presenter: Michael J. Mack, Francesco Maisano, Mayra Guerrero

October 12, 2015

Presentation TCT 2015

Transcatheter Valve Replacement for Mitral Bioprosthetic Valve and Ring Annuloplasty Failures: Multicenter VIVID Registry Results

Presenter: Michael J. Mack, Francesco Maisano, Danny Dvir

October 12, 2015

Presentation TCT 2015

Preoperative Planning for Mitral Valve-in-Valve/Ring Procedures: Integrating Imaging and the Mitral App

Presenter: Michael J. Mack, Francesco Maisano, Vinayak Bapat

October 12, 2015

Presentation TCT 2015

CT Imaging to Guide Selection and Treatment for Transcatheter MV Replacement

Presenter: Michael J. Mack, Francesco Maisano, Jonathon A. Leipsic

October 12, 2015

Presentation TCT 2015

Failure Modes for Transcatheter MV Replacement and Their Implications: Paravalvular Leaks, LVOT, Embolization, and More

Presenter: Michael J. Mack, Francesco Maisano, Paul Sorajja

October 12, 2015

Presentation TCT 2015

Access Site Alternatives for Transcatheter MV Replacement: Transatrial, Transapical, or Transeptal?

Presenter: Michael J. Mack, Francesco Maisano, Nicolo Piazza

October 12, 2015

Presentation TCT 2015

Is Hemodynamic Collapse Due to Increased Afterload After MV Replacement in Severe MR With Reduced LVEF a Real Phenomenon?

Presenter: Michael J. Mack, Francesco Maisano, Patrick M. McCarthy

October 12, 2015

Presentation TCT 2015

For Years Weve Been Hearing Surgical MV Repair Is Always Preferable to Replacement So, Why Transcatheter MV Replacement?!

Presenter: Michael J. Mack, Francesco Maisano, John G. Webb

October 12, 2015

Presentation TCT 2015

PROMISE FFR-CT: Evaluation of FFR-CT in Patients Undergoing Computed Tomographic Angiography for Evaluation of Suspected Coronary Artery Disease

Presenter: Spencer B. King III, Jagat Narula, Michael Lu

October 12, 2015

Presentation TCT 2015

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold Six-Month Clinical, Angiographic, and Imaging Outcomes

Presenter: Dean J. Kereiakes, Ron Waksman, Davide Capodanno, Michael Haude

October 12, 2015

Presentation TCT 2015

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Presenter: Michael J. Lim, Molly Szerlip

October 12, 2015

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

News Conference News TCT 2015

Experts Debate Mitral Valve Repair, Replacement for Intermediate-Risk Patients

October 12, 2015

News Conference News TCT 2015

CT-Derived FFR Could Improve Efficiency of Referral to ICA

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

Advertisement

OPEN CTO - Procedural and 30-Day Results of Hybrid Strategy for CTO Recanalization

Poor Femoral Access and TAVR (Alternative Access): Thoughtful Commentary on the Case

Case 4: Where Are the Guidewires? Two-Stent Treatment Guided by OCT

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold - Six-Month Clinical, Angiographic and Imaging Outcomes

Transcatheter Valve Replacement for Native Mitral Stenosis: International Registry Results

Transcatheter Valve Replacement for Mitral Bioprosthetic Valve and Ring Annuloplasty Failures: Multicenter VIVID Registry Results

Preoperative Planning for Mitral Valve-in-Valve/Ring Procedures: Integrating Imaging and the Mitral App

CT Imaging to Guide Selection and Treatment for Transcatheter MV Replacement

Failure Modes for Transcatheter MV Replacement and Their Implications: Paravalvular Leaks, LVOT, Embolization, and More

Access Site Alternatives for Transcatheter MV Replacement: Transatrial, Transapical, or Transeptal?

Is Hemodynamic Collapse Due to Increased Afterload After MV Replacement in Severe MR With Reduced LVEF a Real Phenomenon?

For Years Weve Been Hearing Surgical MV Repair Is Always Preferable to Replacement So, Why Transcatheter MV Replacement?!

PROMISE FFR-CT: Evaluation of FFR-CT in Patients Undergoing Computed Tomographic Angiography for Evaluation of Suspected Coronary Artery Disease

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold Six-Month Clinical, Angiographic, and Imaging Outcomes

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

Experts Debate Mitral Valve Repair, Replacement for Intermediate-Risk Patients

CT-Derived FFR Could Improve Efficiency of Referral to ICA

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content